Johannes Kornhuber Selected Research

Vagus Nerve Stimulation

9/2013	The effects of stimulation parameters on clinical outcomes in patients with vagus nerve stimulation implants with major depression.
8/2010	Vagus-nerve stimulation is tolerated in a patient with cardiac AV-Blocks.
6/2010	Vagus-nerve stimulation is tolerated in a patient with cardiac AV-blocks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johannes Kornhuber Research Topics

Disease

113	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 01/2003
67	Alcoholism (Alcohol Abuse) 01/2024 - 05/2004
62	Dementia (Dementias) 04/2024 - 01/2003
47	Cognitive Dysfunction 04/2024 - 11/2005
18	Major Depressive Disorder (Major Depressive Disorders) 03/2024 - 11/2009
15	Mental Disorders (Mental Disorder) 05/2024 - 09/2003
15	Schizophrenia (Dementia Praecox) 01/2021 - 08/2003
13	Atrophy 01/2023 - 04/2003
11	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2004
9	COVID-19 11/2023 - 11/2020
9	Infections 08/2023 - 01/2014
8	Disease Progression 03/2024 - 02/2015
8	Feeding and Eating Disorders (Eating Disorder) 03/2024 - 10/2006
8	Frontotemporal Dementia (Semantic Dementia) 01/2024 - 10/2008
8	Seizures (Absence Seizure) 01/2016 - 11/2004
8	Alcohol Withdrawal Seizures 01/2012 - 05/2004
6	Parkinson Disease (Parkinson's Disease) 03/2024 - 05/2006
6	Inflammation (Inflammations) 01/2024 - 01/2014
6	Mood Disorders (Mood Disorder) 01/2023 - 07/2013
6	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2023 - 01/2011
6	Substance-Related Disorders (Drug Abuse) 01/2021 - 09/2012
6	Amyloid Plaque 01/2018 - 05/2006
6	Bulimia Nervosa 12/2012 - 01/2008
5	Depressive Disorder (Melancholia) 09/2023 - 04/2010
5	Neoplasms (Cancer) 01/2018 - 01/2014
5	Anorexia Nervosa 12/2012 - 01/2008
4	Binge Drinking 01/2024 - 01/2018
4	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 12/2004
4	Pain (Aches) 05/2020 - 11/2004
4	Niemann-Pick Diseases (Niemann Pick Disease) 01/2019 - 01/2013
4	Tobacco Use Disorder (Nicotine Dependence) 11/2012 - 03/2010
4	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2012 - 04/2008
3	Treatment-Resistant Depressive Disorder 01/2022 - 09/2013
3	Vesicular Stomatitis 01/2021 - 11/2020
3	Virus Diseases (Viral Diseases) 11/2020 - 07/2012
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020 - 01/2018
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2018 - 04/2011
3	Primary Progressive Aphasia 01/2018 - 01/2011
3	Body Weight (Weight, Body) 01/2013 - 06/2011
3	Open-Angle Glaucoma (Glaucoma, Open Angle) 04/2005 - 12/2003

Drug/Important Bio-Agent (IBA)

95	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2004
36	Amyloid (Amyloid Fibrils)IBA 04/2024 - 01/2011
33	Amyloid beta-PeptidesIBA 04/2024 - 01/2003
28	HomocysteineIBA 12/2018 - 04/2003
26	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 08/2023 - 01/2010
26	Peptides (Polypeptides)IBA 01/2021 - 01/2003
23	AcidsIBA 08/2023 - 01/2010
22	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2004
20	CeramidesIBA 08/2023 - 11/2009
16	Antidepressive Agents (Antidepressants)IBA 01/2023 - 07/2006
15	Apolipoproteins E (ApoE)IBA 01/2022 - 11/2007
14	EnzymesIBA 03/2024 - 07/2004
11	LipidsIBA 03/2024 - 10/2011
10	Messenger RNA (mRNA)IBA 12/2012 - 12/2004
9	SphingolipidsIBA 03/2024 - 01/2014
9	Gonadal Steroid Hormones (Sex Hormones)IBA 08/2023 - 01/2012
9	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 08/2003
8	ApolipoproteinsIBA 01/2020 - 11/2007
8	tau Proteins (tau Protein)IBA 01/2018 - 01/2004
7	LeptinIBA 01/2021 - 12/2005
7	alpha-SynucleinIBA 04/2019 - 12/2004
6	AndrogensIBA 08/2023 - 08/2009
6	CytokinesIBA 01/2018 - 02/2012
6	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2017 - 04/2010
5	Fluoxetine (Prozac)FDA LinkGeneric 11/2022 - 08/2010
5	Apolipoprotein E4IBA 01/2022 - 11/2005
5	Testosterone (Sustanon)FDA Link 01/2021 - 05/2010
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 02/2012
4	SynucleinsIBA 03/2024 - 02/2013
4	Hormones (Hormone)IBA 01/2024 - 12/2007
4	Amphetamine (Amfetamine)FDA LinkGeneric 04/2023 - 11/2018
4	Nerve Growth Factor (NGF)IBA 01/2019 - 08/2008
4	DNA (Deoxyribonucleic Acid)IBA 03/2015 - 02/2005
4	CholesterolIBA 07/2014 - 11/2010
4	Androgen Receptors (Androgen Receptor)IBA 05/2014 - 03/2011
4	ProlactinIBA 02/2011 - 01/2006
3	Estrogens (Estrogen)FDA Link 08/2023 - 05/2016
3	ethyl glucuronideIBA 08/2023 - 04/2010
3	Threonine (L-Threonine)FDA Link 01/2023 - 01/2004
3	Neuropeptide YIBA 07/2022 - 01/2012
3	N-Methylaspartate (NMDA)IBA 01/2022 - 05/2004
3	Amitriptyline (Elavil)FDA LinkGeneric 01/2021 - 01/2016
3	Heroin (Diamorphine)IBA 01/2021 - 01/2012
3	SARS-CoV-2 spike proteinIBA 01/2021 - 11/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2010
3	Blood Alcohol ContentIBA 12/2018 - 03/2005
3	Urea (Carbamide)FDA LinkGeneric 01/2018 - 09/2004
3	EndocannabinoidsIBA 01/2017 - 05/2009
3	Memantine (Namenda)FDA Link 11/2015 - 08/2003
3	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 05/2014 - 12/2007
3	Glutamic Acid (Glutamate)FDA Link 07/2012 - 09/2003
3	OrexinsIBA 01/2012 - 06/2011
3	hydrogen sulfite (bisulfite)IBA 09/2011 - 04/2010
3	GhrelinIBA 01/2009 - 12/2005
2	Glial Fibrillary Acidic ProteinIBA 03/2024 - 01/2019

Therapy/Procedure

14	Therapeutics 10/2022 - 01/2003
7	Drug Therapy (Chemotherapy) 01/2021 - 01/2003
4	Transcranial Magnetic Stimulation 05/2024 - 11/2004
4	Activities of Daily Living (ADL) 01/2020 - 02/2009
3	Vagus Nerve Stimulation 09/2013 - 06/2010